DSM and Roquette Take Next Step in Bio-Based Succinic Acid
GELEEN, the Netherlands – Following the successful production of bio-succinic acid under the trademark Biosuccinium® since 2012, Reverdia’s parent companies — Royal DSM and Roquette — have decided on a strategic shift in the continuing operations of their joint venture.
Effective April 1, 2019, the joint venture Reverdia will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium plant in Cassano, Italy, to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium technology, will assume the role of exclusive licensor, in line with its business model in this field.